CTIS.eu › Cities › Lithuania › Klaipeda
Klaipeda
Lithuania
62 total trials
14 recruiting
2022-501361-44-00
5
Adult patients of either gender with active moderate to severe rheumat
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2023-509255-14-01
4
Advanced prostate cancer
2025-522471-28-00
5
psoriatic arthritis (PsA)
2024-519423-24-00
5
2025-10-07
Major Depressive Disorder
2024-518589-29-00
5
2025-08-21
Bronchiectasis
2022-501354-10-01
5
2023-06-21
axial spondyloarthritis
2022-500257-16-00
5
2023-03-17
Diabetic Foot Infections
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
2025-521242-26-00
4
2025-11-27
Moderately to Severely Active Ulcerative Colitis
2025-520478-20-00
5
2025-11-05
Thromboembolic disease
2024-519420-25-00
5
2025-10-22
Major Depressive Disorder
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
2024-519688-16-00
4
2025-08-07
venous thromboembolism
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
2024-514539-67-00
4
2025-06-27
Systemic Sclerosis
2023-508581-15-00
5
2024-10-08
Heart condition
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
2025-520488-42-00
4
2025-09-17
Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
2024-512914-16-00
5
2025-09-12
Relapsing-remitting Multiple Sclerosis
2024-516213-20-00
5
2025-03-25
Psoriatic arthritis
2024-513160-25-00
5
2024-10-30
Melanoma and Non-small-cell lung cancer
2023-503655-10-00
5
2023-11-20
Systemic Lupus Erythematosus (SLE).
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
Showing 1–24 of 62 trials